Abstract:Gliomas are the most common primary central nervous system tumors and account for approximately 80% of malignant brain tumors. MicroRNAs (miRNAs) are a class of small non-coding, regulatory RNA molecules that mediate the expression levels of specific proteins. As a member of the miRNA family, miR-543 plays a tumor suppressive or an oncogenic role in different types of tumors. However, the expression and role of miR-543 in glioma remain unknown. In the present study, the expression level of miR-543 in glioma cell lines and tissues was investigated. A series of in vitro and in vivo experiments was then performed to elucidate the function of miR-543 in glioma. Moreover, proteomic profiling was applied in this study to determine the landscape of differentially expressed proteins associated with miR-543-mediated carcinogenesis in glioma. We found that the expression level of miR-543 was greatly downregulated in glioma cell lines and tissues. Furthermore, the expression level of miR-543 was negatively associated with high-grade glioma. Functional studies demonstrated that miR-543 in glioma cells induced apoptosis and inhibited growth, the cell cycle, migration and invasion. In addition, the in vivo study showed that miR-543 suppressed tumorigenicity of glioma cells. In the present study, a label-free quantitative proteomic approach was performed and 339 proteins were identified as dysregulated after miR-543 was overexpressed. Among these dysregulated proteins, 165 were upregulated and 174 were downregulated. Moreover, multiple pathways were significantly enriched and were probably involved in miR-543-mediated tumorigenesis, including RNA degradation and the inositol phosphate metabolism pathway. In conclusion, miR-543 may function as a tumor suppressor in glioma and may serve as a future therapeutic target in therapy for patients with glioma.

MicroRNA-509-3p Inhibits Cell Proliferation and Invasion Via Downregulation of X-linked Inhibitor of Apoptosis in Glioma.

MicroRNA-409-3p Represses Glioma Cell Invasion and Proliferation by Targeting High-Mobility Group Nucleosome-Binding Domain 5.

MicroRNA-320 Inhibits Cell Proliferation in Glioma by Targeting E2F1

Microrna-138 Modulates Glioma Cell Growth, Apoptosis And Invasion Through The Suppression Of The Akt/Mtor Signalling Pathway By Targeting Creb1

Mir-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells

MicroRNA-140-5p Inhibits Cell Proliferation and Invasion by Regulating VEGFA/MMP2 Signaling in Glioma

microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma.

MicroRNA-338-5p Plays a Tumor Suppressor Role in Glioma Through Inhibition of the MAPK-signaling Pathway by Binding to FOXD1

Microrna-497-5p Targeted Sox9 To Inhibit Proliferation, Migration And Invasion Of Glioma Cells

MicroRNA-16-5p Inhibits the Proliferation and Invasion of Glioma Cells by the Activation of P53/bax Signal Pathway

miRNA-338-3p inhibits glioma cell proliferation and progression by targeting MYT1L

MicroRNA-16 Inhibits Glioma Cell Growth and Invasion Through Suppression of BCL2 and the Nuclear Factor-Κb1/mmp9 Signaling Pathway.

MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1R.

MiRNA-451 plays a role as tumor suppressor in human glioma cells.

MicroRNA-203 inhibits the proliferation and invasion of U251 glioblastoma cells by directly targeting PLD2.

Microrna-610 is Downregulated in Glioma Cells, and Inhibits Proliferation and Motility by Directly Targeting Mdm2

Microrna-1471 Suppresses Glioma Cell Growth and Invasion by Repressing Metadherin Expression.

MicroRNA-375 Inhibits Glioma Cell Proliferation and Migration by Downregulating RWDD3 Inï¿½vitro

miR-543 functions as a tumor suppressor in glioma in vitro and in vivo

miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.

MicroRNA-199a-3p Suppresses Glioma Cell Proliferation by Regulating the AKT/mTOR Signaling Pathway.